+ All Categories
Home > Documents > Presentation - Statistical Considerations in Setting Acceptance Criteria

Presentation - Statistical Considerations in Setting Acceptance Criteria

Date post: 11-Feb-2022
Category:
Upload: others
View: 7 times
Download: 0 times
Share this document with a friend
22
Federal Institute for Vaccines and Biomedicines 09.09.2011 Kay-Martin Hanschmann 1 1. Reference intervals (and outlier tests) 2. Tolerance intervals 3. Process performance indices, 6 sigmas, … 4. Summary Statistical Considerations in Setting Acceptance Criteria Statistical Considerations in Setting Acceptance Criteria Disclaimer The views expressed here are those of the author and may not necessary reflect those of the German Regulatory Authorities
Transcript
Page 1: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011Kay-Martin Hanschmann 1

1.

Reference intervals (and outlier tests)2.

Tolerance intervals

3.

Process performance indices, 6 sigmas, …4.

Summary

Statistical Considerations in Setting Acceptance CriteriaStatistical Considerations in Setting Acceptance Criteria

DisclaimerThe views expressed here are those of the author and may not necessary reflect those of the German Regulatory Authorities

Page 2: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 2

Reference IntervalsReference Intervals

Mean ±

2 standard deviations (Mean ±

3 s)•

Easy to implement

Data should be symmetrically (ideal: normally) distribu•

Otherwise: Transformation of the data

Reliable, unbiased estimation of mean and standard deviation necessary

Kay-Martin Hanschmann

Page 3: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 3

1-2-3-σ-Rule Reference Intervals include a certain amount of the data

(assumption: normal distribution)

95% of the data can be found in the interval [Mean -

2 s, Mean + 2s]

Or: With 95% probability a value lies in this interval

1. Reference Intervals

Interval ProbabilityMean ±

… Within Outside… 1 s 0.683 0.317… 2 s 0.954 0.046… 3 s 0.998 0.003… 1.64 s 0.900 0.100… 1.96 s 0.950 0.050… 2.58 s 0.990 0.010

Kay-Martin Hanschmann

Page 4: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

measured

Perc

ent

-100 0 100 200 3000

5

10

15

20

09.09.2011 4Kay-Martin Hanschmann

Mean ±

2 SD covers about 95% of the data

Mean ±

3 SD covers about 99% of the data

1. Reference Intervals

Mean ±

6 SD covers…? –

possibly too much!

Page 5: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

measured

Perc

ent

0 50 100 150 200 250 300 350 400 450 5000

5

10

15

20

25

09.09.2011 5Kay-Martin Hanschmann

1. Reference Intervals

Skewed distributions / non-normal distributed data: Transformation of data (→ skewed specification)

Specification39.8 –

251.2 (Mean ±

2s, of logarithmised data)

Page 6: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 6Kay-Martin Hanschmann

1. Reference Intervals

How much data needed to set up specifications?

N=10,000

N=100

N=12

95%-ConfidenceInterval[99.3 –

100.5][29.6 –

30.4]

measured

Perc

ent

0 50 100 150 2000

5

10

15

20

95%-ConfidenceInterval[95.0 –

106.8][26.3 –

34.8]

measured

Perc

ent

0 50 100 150 2000

5

10

15

20

95%-ConfidenceInterval[76.6 –

115.8][21.9 –

52.5]

measured

Perc

ent

0 50 100 150 2000

5

10

15

20

Page 7: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 7Kay-Martin Hanschmann

1. Reference Intervals

Example Reference Interval IMean +/-2s as “warning”

limits,

Mean +/-3s as “intervention”

limits(validated with 10 samples)

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredmean +/- 2smean +/- 3s

VALIDATION “bad“

batches (sub-potent, not safe, …)

“bad“

batches (sub-potent, not safe, …)

“grey area”

“grey area”

Page 8: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 8Kay-Martin Hanschmann

1. Reference Intervals

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredmean +/- 2smean +/- 3s

VALIDATION

Example Reference Interval IIMean +/-2s as “warning”

limits,

Mean +/-3s as “intervention”

limits(validated with 10 samples)

Page 9: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 9Kay-Martin Hanschmann

1. Outlier tests

Outliers and outlier testsIs it an outlier? –

Or does it belong to the population?

It depends on how much information we have…

Torere, Bay of Plenty, New Zealand

Page 10: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 10Kay-Martin Hanschmann

1. Outlier tests

There are several outlier tests…

but be careful using them!

1.30 1.35 1.40 1.45 1.50 1.55 1.60 1.65

outlier?

1.30 1.35 1.40 1.45 1.50 1.55 1.60 1.65

1.30 1.35 1.40 1.45 1.50 1.55 1.60 1.65

outlier?outlier?

0 1 2 3 4

outlieraccordingDixon’s test

Page 11: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 11Kay-Martin Hanschmann

Tolerance IntervalsTolerance IntervalsIntervals that cover percentiles of the population with a certain probability

Non-parametric TI –

percentiles:

Example: [p0.05

– p0.95

] might serve as TI for the mean 90% of the population

Example: Smallest –

largest observation [y(1)

– y(n)

] might serve as TI for whole population

BUT: To cover actually 90% of the population with [y(1)

– y(n)

], N=19 measurements are necessary●

AND: To cover actually 90% of the population with [y(1)

– y(n)

] with 95% probability, N=46 measurements are necessary

Page 12: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 12Kay-Martin Hanschmann

2. Tolerance Intervals

TI (2–sided) for normal distributed data:

Guttman (1970), Rasch (1996)

Page 13: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 13Kay-Martin Hanschmann

2. Tolerance Intervals

TI (2–sided) for normal distributed data:

Howe (1969)

Page 14: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 14Kay-Martin Hanschmann

2. Tolerance Intervals

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredTolerance Interval

Page 15: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 15Kay-Martin Hanschmann

2. Tolerance Intervals

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredTolerance Interval

Dynamic Tolerance IntervalsWhat about early OOS results? May belong to population –

or may be OOS!

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredTolerance Interval

Page 16: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 16Kay-Martin Hanschmann

2. Tolerance Intervals

Dynamic Tolerance IntervalsTI widens, when data shows a trend –

may lead to undesired effects

# batches tested0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30

-60

-40

-20

0

20

40

60

80

100

120

measuredTolerance Interval

Page 17: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 17Kay-Martin Hanschmann

2. Tolerance Intervals

Fixed Tolerance IntervalsWith a sufficient amount of validation data the TI will be more reliable

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredTolerance Interval

VALIDATION

Page 18: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 18Kay-Martin Hanschmann

2. Tolerance Intervals

Two-Step Approach

# batches tested0 2 4 6 8 10 12 14 16 18 20

-60

-40

-20

0

20

40

60

80

measuredTolerance Interval

VALIDATION RE-VALIDATION

Page 19: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 19Kay-Martin Hanschmann

Process performance indices, 6 sigmas, …Process performance indices, 6 sigmas, …

-

PPI: Similar to reference limits (mean ±

3SD x Ppu)

-

Advantage to be product specific-

BUT: Wouldn’t such limits be to wide (and could include e.g. OOS batches)?

-

At least: Limits must exclude range, where sub- potency, non-safety, …

starts

-

Thus: 6 sigmas are not recommended (for normal or similar distributed data these would include anything)

Page 20: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 20Kay-Martin Hanschmann

Crucial: Reliable estimation of the specification limits-Too narrow intervals could result in too many re-tests and / or falsely rejected batches-Too wide intervals could lead to falsely released batches (sub-potent, safety concerns, …)

SummarySummary

-

Specification based on what we have observed so far (might be few), thus future results may represent what we missed in validation

-

Samples used for validation were too homogeneous (too narrow specifications) –

bad luck?-

Samples used for validation had high variability (new processes,

untrained personnel, too wide specifications)-

Validation performed with few samples, repeatedly tested (should

be avoided!)

Page 21: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 21Kay-Martin Hanschmann

-

For a complete new product it will be difficult to set up reliable specification limits with only 3 batches/tests

-

risk of miss-specification might be high, especially if variability of parameter of interest is expected to be high; a re-validation should be planned (n=8-12 batches) → 2-step-approach

Summary IISummary II

-

No universal tool available –

parameter / product dependent-

Aim to obtain high sensitivity to detect critical batches (sub-

potent, safety risks, …) and-

To obtain high specificity in order to avoid false negative results and to limit unnecessary re-tests

Page 22: Presentation - Statistical Considerations in Setting Acceptance Criteria

Federal Institute for Vaccines and Biomedicines

09.09.2011 22

Thank you for your attention

Kay-Martin Hanschmann


Recommended